Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02662907 · ClinicalTrials.gov registry record · NA

Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy

A NA study of Head and Neck Cancer, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT02662907: Active NA study of Head and Neck Cancer, sponsored by M.D. Anderson Cancer Center.

NCT02662907 is a NA study of Head and Neck Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 175 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02662907, a NA study of Head and Neck Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to learn if exercising the muscles that help you cough and swallow, called expiratory muscle strength training (EMST), can help reduce the risk of pneumonia due to aspiration (inhaling saliva instead of swallowing it) in patients who have had radiation for head and neck cancer.

Primary Outcome

Primary analysis is association between baseline Penetration-Aspiration Scale (PAS) scores and baseline maximum expiratory pressures (MEPs). Analysis examined by plotting the data and computing a polyserial correlation coefficient. Participants with PAS≥6 coded as aspirators.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaires
  • PROCEDURE Barium Swallow
  • DEVICE Expiratory Muscle Strength Training (EMST) Device
  • DEVICE Digital Manometer
  • BEHAVIORAL Neurocognitive Exams

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2016-02-01
Est. Completion 2027-02-02
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT02662907 still lists

NCT02662907 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (33% lower).

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.

NCT02662907 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02662907 about?

NCT02662907 is a clinical study titled "Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy". The goal of this clinical research study is to learn if exercising the muscles that help you cough and swallow, called expiratory muscle strength training (EMST), can help reduce the risk of pneumonia due to aspiration (inhaling saliva instead of swallowing it) in patients who have had radiation for...

What is the current status of trial NCT02662907?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2016-02-01. Estimated completion is 2027-02-02.

What conditions does trial NCT02662907 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT02662907?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Barium Swallow (PROCEDURE), Expiratory Muscle Strength Training (EMST) Device (DEVICE), Digital Manometer (DEVICE), Neurocognitive Exams (BEHAVIORAL).

Who is sponsoring clinical trial NCT02662907?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02662907 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02662907's enrollment target sits among peer trials

175 55th of 250 higher than 196 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02662907, the US trial registry maintained by the National Library of Medicine. NCT02662907 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.